These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34608846)

  • 1. Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice.
    Zhao C; Cui X; Zhao Y; Qian B; Zhang N; Xin L; Ha C; Yang J; Wang X; Gao X
    Bioengineered; 2021 Dec; 12(1):7360-7375. PubMed ID: 34608846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
    Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
    Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance.
    Wang X; Xin L; Duan Z; Zuo Z; Wang Y; Ren Y; Zhang W; Sun X; Liu X; Ge L; Yang X; Yao Z; Yang J
    FASEB J; 2019 Mar; 33(3):3731-3745. PubMed ID: 30521378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
    Bartelt A; Orlando P; Mele C; Ligresti A; Toedter K; Scheja L; Heeren J; Di Marzo V
    Diabetologia; 2011 Nov; 54(11):2900-10. PubMed ID: 21847582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of voltage-gated proton channel Hv1 leads to diet-induced obesity in mice.
    Pang H; Li J; Du H; Gao Y; Lv J; Liu Y; Li SJ
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.
    Xu JL; Li LY; Wang YQ; Li YQ; Shan M; Sun SZ; Yu Y; Wang B
    J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
    Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
    Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
    Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
    Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
    Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
    Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
    Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific METTL3 ablation by Alb-iCre mice (GPT), but not by Alb-Cre mice (JAX), resulted in acute liver failure (ALF) and postnatal lethality.
    Huang S; Li Y; Wang B; Zhou Z; Li Y; Shen L; Cong J; Han L; Xiang X; Xia J; He D; Zhao Z; Zhou Y; Li Q; Dai G; Shen H; Lin T; Wu A; Jia J; Xiao D; Li J; Zhao W; Lin X
    Aging (Albany NY); 2024 Apr; 16(8):7217-7248. PubMed ID: 38656880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
    Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
    Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance.
    Kang HS; Liao G; DeGraff LM; Gerrish K; Bortner CD; Garantziotis S; Jetten AM
    PLoS One; 2013; 8(3):e58417. PubMed ID: 23505504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
    Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
    Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.
    Sheng L; Liu Y; Jiang L; Chen Z; Zhou Y; Cho KW; Rui L
    PLoS One; 2013; 8(12):e83269. PubMed ID: 24358267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatic HSP72 on insulin signaling.
    Kitano S; Kondo T; Matsuyama R; Ono K; Goto R; Takaki Y; Hanatani S; Sakaguchi M; Igata M; Kawashima J; Motoshima H; Matsumura T; Kai H; Araki E
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E305-E318. PubMed ID: 30532989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.